PROCEPT BioRobotics (PRCT) Consolidated Net Income (2020 - 2026)
PROCEPT BioRobotics (PRCT) posted quarterly Consolidated Net Income of -$31.6 million for Q1 2026, down 27.9% year-over-year from -$43.9 million in Q1 2025, and up 0.73% quarter-over-quarter from -$31.9 million in Q4 2025.
PROCEPT BioRobotics (PRCT) Consolidated Net Income (2020 - 2026) Analysis & Trends
PROCEPT BioRobotics (PRCT) has reported Consolidated Net Income for 7 consecutive years, with -$31.6 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Consolidated Net Income fell 27.9% year-over-year to -$31.6 million; the TTM figure through Mar 2026 stood at -$185.1 million (down 64.85% YoY), while the FY2025 annual figure was -$95.6 million, down 4.55% from the prior year.
- Consolidated Net Income climbed to -$31.6 million in Q1 2026 per PRCT's latest filing, from -$31.9 million in the prior quarter.
- Across five years, Consolidated Net Income topped out at -$19.3 million in Q2 2022 and bottomed at -$78.0 million in Q1 2023.
- Historically, Consolidated Net Income has averaged -$36.8 million across 5 years, with a median of -$31.9 million in 2025.
- Annual changes were most pronounced in 2023 — Consolidated Net Income plunged 296.97% — and 2024, when it soared 46.71%.
- PROCEPT BioRobotics' Consolidated Net Income stood at -$24.0 million in 2022, then tumbled by 33.97% to -$32.1 million in 2023, then surged by 35.08% to -$20.8 million in 2024, then plunged by 52.88% to -$31.9 million in 2025, then gained by 0.73% to -$31.6 million in 2026.
- Business Quant data shows PRCT's Consolidated Net Income at -$31.6 million in Q1 2026, -$31.9 million in Q4 2025, and -$60.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Consol Net Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.20 Bn | 194.60 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Stryker | 129.69 Bn | 126.21 Bn | 4.50 Bn | 1.28 Bn |
| 3 | Medtronic | 120.14 Bn | 110.92 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 74.16 Bn | 73.62 Bn | 3.85 Bn | 905.00 Mn |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn | 241.40 Mn |
| 6 | Dexcom | 34.57 Bn | 32.62 Bn | 830.00 Mn | 249.10 Mn |
| 7 | GE HealthCare Technologies | 34.09 Bn | 31.98 Bn | 2.18 Bn | 574.00 Mn |
| 8 | Koninklijke Philips | 26.49 Bn | 23.17 Bn | 4.55 Bn | 1.04 Bn |
| 9 | Steris | 23.19 Bn | 22.70 Bn | 684.20 Mn | 201.00 Mn |
| 10 | PROCEPT BioRobotics | 1.23 Bn | 958.13 Mn | 62.38 Mn | -26.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -26.86 Mn |
| Mar 31, 2026 | -31.64 Mn |
| Dec 31, 2025 | -31.87 Mn |
| Sep 30, 2025 | -60.75 Mn |
| Jun 30, 2025 | -60.82 Mn |
| Mar 31, 2025 | -24.74 Mn |
| Dec 31, 2024 | -20.85 Mn |
| Sep 30, 2024 | -35.05 Mn |
| Jun 30, 2024 | -31.64 Mn |
| Mar 31, 2024 | -41.54 Mn |
| Dec 31, 2023 | -32.12 Mn |
| Sep 30, 2023 | -30.04 Mn |
| Jun 30, 2023 | -44.05 Mn |
| Mar 31, 2023 | -77.96 Mn |
| Dec 31, 2022 | -23.97 Mn |
| Sep 30, 2022 | -39.54 Mn |
| Jun 30, 2022 | -19.32 Mn |
| Mar 31, 2022 | -19.64 Mn |
| Dec 31, 2021 | -18.02 Mn |
| Sep 30, 2021 | -17.94 Mn |